Jay Bhattacharya, the director of the National Institutes of Health (NIH), has revealed that a recent multi-million-dollar research contract for mRNA technology was canceled by the federal government, citing a lack of public trust in this approach.
In a podcast episode of “War Room” with Republican strategist Steve Bannon, as well as in an OP-ED piece, Bhattacharya discussed the motivations behind this abrupt decision.
He characterized the mRNA platform as “a promising technology” and acknowledged its potential for advancing treatments for diseases like cancer.
However, he noted that it has not passed crucial evaluations, particularly as a vaccine designed for widespread public use during health crises.
“Regardless of the sophistication of science,” he stated, “unreliable platforms cannot fulfill the public health mission.”
His comments about the government’s shift away from mRNA technology contrast with those of his superior, Health and Human Services Director Robert F. Kennedy Jr.
Recently, Kennedy indicated that his agency would end mRNA vaccine initiatives under the Biomedical Advanced Research and Development Agency (BARDA) and terminate a contract valued at $500 million related to this technology.
He pointed out that the mRNA technology, initially funded during the pandemic, did not meet current scientific benchmarks, leading to a pivot towards all-virus vaccines and alternative platforms.
Bhattacharya expressed concerns about the mRNA vaccine’s ability to generate spike proteins in human cells and invoke an immune response. He suggested that the scientific community lacks a comprehensive understanding of where mRNA products remain in the body and the duration of protein production.
Scott Hensley, a microbiology professor at the University of Pennsylvania, shared his views with Statistics News, noting that similar issues exist with vaccines employing live weakened viruses, like those for measles, mumps, and rubella, which federal health agencies affirm are safe and effective.
“This underscores why vaccines undergo rigorous clinical human trials before they are widely administered,” he explained. “Both mRNA and resistance-attenuated vaccine platforms have demonstrated safety and efficacy in clinical studies.”
Hensley criticized the public’s skepticism towards the mRNA vaccines stemming from the Biden administration’s mandates during the pandemic.
In his OP-ED, Bhattacharya remarked, “Science is not propaganda; it’s about humility. When public health officials lost that humility in their communication, they alienated a significant portion of the public.”
A spokesperson for the Department of Health and Human Services did not respond promptly to inquiries from the Hill.
